Atoosa Rabiee
@atoosarabiee.bsky.social
Transplant hepatologist
Chief of Transplant|Director of Hepatology @DCVAMC @HopkinsMedicine@UMiamiHealth
#liversky|#livercancer|#portalHT|#MEDed
Chief of Transplant|Director of Hepatology @DCVAMC @HopkinsMedicine@UMiamiHealth
#liversky|#livercancer|#portalHT|#MEDed
Reposted by Atoosa Rabiee
Had a great last day at #TLM2025 with inspiration and food for 🤔
👀 all 7 women @aasldnews.bsky.social presidents in one room (‼️) for the Women’s Luncheon
🔥🔥🔥discussion by @LaurenFeldMD and division chiefs on recruitment & retention of women hepatologists
#liversky
👀 all 7 women @aasldnews.bsky.social presidents in one room (‼️) for the Women’s Luncheon
🔥🔥🔥discussion by @LaurenFeldMD and division chiefs on recruitment & retention of women hepatologists
#liversky
November 10, 2025 at 10:49 PM
Had a great last day at #TLM2025 with inspiration and food for 🤔
👀 all 7 women @aasldnews.bsky.social presidents in one room (‼️) for the Women’s Luncheon
🔥🔥🔥discussion by @LaurenFeldMD and division chiefs on recruitment & retention of women hepatologists
#liversky
👀 all 7 women @aasldnews.bsky.social presidents in one room (‼️) for the Women’s Luncheon
🔥🔥🔥discussion by @LaurenFeldMD and division chiefs on recruitment & retention of women hepatologists
#liversky
Next gen hepatology
Session by communication and technology committee
All brilliant speakers!
Proud to have served as the chair of this committee
@aasldnews.bsky.social
#TLM25
#liversky
@howardtleemd.bsky.social
Session by communication and technology committee
All brilliant speakers!
Proud to have served as the chair of this committee
@aasldnews.bsky.social
#TLM25
#liversky
@howardtleemd.bsky.social
November 10, 2025 at 4:04 PM
Next gen hepatology
Session by communication and technology committee
All brilliant speakers!
Proud to have served as the chair of this committee
@aasldnews.bsky.social
#TLM25
#liversky
@howardtleemd.bsky.social
Session by communication and technology committee
All brilliant speakers!
Proud to have served as the chair of this committee
@aasldnews.bsky.social
#TLM25
#liversky
@howardtleemd.bsky.social
Reposted by Atoosa Rabiee
📣 NEW 💫 class of @aasldnews.bsky.social Women’s Leadership Development program mentees & mentors
It was lovely to celebrate you with an inspiring keynote talk from #AASLD25 President Dr. Grace Su
Looking forward to the year ahead!
#TLM2025 #liversky #gisky
It was lovely to celebrate you with an inspiring keynote talk from #AASLD25 President Dr. Grace Su
Looking forward to the year ahead!
#TLM2025 #liversky #gisky
November 10, 2025 at 10:58 AM
📣 NEW 💫 class of @aasldnews.bsky.social Women’s Leadership Development program mentees & mentors
It was lovely to celebrate you with an inspiring keynote talk from #AASLD25 President Dr. Grace Su
Looking forward to the year ahead!
#TLM2025 #liversky #gisky
It was lovely to celebrate you with an inspiring keynote talk from #AASLD25 President Dr. Grace Su
Looking forward to the year ahead!
#TLM2025 #liversky #gisky
Reposted by Atoosa Rabiee
➡️What happens when you increase salary transparency?
➡️What is on a chief’s 🧠when negotiating a new hire?
➡️How to ⚖️ accommodations & consistency?
Find out in our 🔥🔥 #TLM2025 panel
@aasldnews.bsky.social #liversky @ast-whcop.bsky.social @ast-licop.bsky.social
➡️What is on a chief’s 🧠when negotiating a new hire?
➡️How to ⚖️ accommodations & consistency?
Find out in our 🔥🔥 #TLM2025 panel
@aasldnews.bsky.social #liversky @ast-whcop.bsky.social @ast-licop.bsky.social
November 10, 2025 at 11:27 AM
➡️What happens when you increase salary transparency?
➡️What is on a chief’s 🧠when negotiating a new hire?
➡️How to ⚖️ accommodations & consistency?
Find out in our 🔥🔥 #TLM2025 panel
@aasldnews.bsky.social #liversky @ast-whcop.bsky.social @ast-licop.bsky.social
➡️What is on a chief’s 🧠when negotiating a new hire?
➡️How to ⚖️ accommodations & consistency?
Find out in our 🔥🔥 #TLM2025 panel
@aasldnews.bsky.social #liversky @ast-whcop.bsky.social @ast-licop.bsky.social
Best practices of management of obesity in liver transplant
FANTASTIC work by @drjessicadavis.bsky.social et al leading a controversy conference and consensus paper 👇🏼👇🏼👇🏼
Her beautiful graph won the cover photo 👌🏼
#liversky
#TLM25
@aasldnews.bsky.social
@ast-licop.bsky.social
FANTASTIC work by @drjessicadavis.bsky.social et al leading a controversy conference and consensus paper 👇🏼👇🏼👇🏼
Her beautiful graph won the cover photo 👌🏼
#liversky
#TLM25
@aasldnews.bsky.social
@ast-licop.bsky.social
November 9, 2025 at 4:09 PM
Best practices of management of obesity in liver transplant
FANTASTIC work by @drjessicadavis.bsky.social et al leading a controversy conference and consensus paper 👇🏼👇🏼👇🏼
Her beautiful graph won the cover photo 👌🏼
#liversky
#TLM25
@aasldnews.bsky.social
@ast-licop.bsky.social
FANTASTIC work by @drjessicadavis.bsky.social et al leading a controversy conference and consensus paper 👇🏼👇🏼👇🏼
Her beautiful graph won the cover photo 👌🏼
#liversky
#TLM25
@aasldnews.bsky.social
@ast-licop.bsky.social
Real-world data in clinical practice
-identify CSPH with VTCE & Plt
-VTCE15-20+plt <110
-VTCE 20-20+ plt < 150
-VTCE >20 + any plt
-NSBB for cACLD with CSPH
- Telepression+Albumin - 1st line for HRS-AKI
-Resp Failure Risks- ACLF3 & Hypoxia
#TLM25 @aasldnews.bsky.social
-identify CSPH with VTCE & Plt
-VTCE15-20+plt <110
-VTCE 20-20+ plt < 150
-VTCE >20 + any plt
-NSBB for cACLD with CSPH
- Telepression+Albumin - 1st line for HRS-AKI
-Resp Failure Risks- ACLF3 & Hypoxia
#TLM25 @aasldnews.bsky.social
November 9, 2025 at 12:01 AM
Recompensation take home points
⏳off all diuretics and medications for HE
📌happens in 1 out of 3 patients depending etiology
🖋️multiple factors affect it
🔎 improves survival and LR mortality
📍Risk of HCC remains the same: don’t stop screening
@anahitarabiee.bsky.social
#liversky
#TLM25
⏳off all diuretics and medications for HE
📌happens in 1 out of 3 patients depending etiology
🖋️multiple factors affect it
🔎 improves survival and LR mortality
📍Risk of HCC remains the same: don’t stop screening
@anahitarabiee.bsky.social
#liversky
#TLM25
November 8, 2025 at 1:50 PM
Recompensation take home points
⏳off all diuretics and medications for HE
📌happens in 1 out of 3 patients depending etiology
🖋️multiple factors affect it
🔎 improves survival and LR mortality
📍Risk of HCC remains the same: don’t stop screening
@anahitarabiee.bsky.social
#liversky
#TLM25
⏳off all diuretics and medications for HE
📌happens in 1 out of 3 patients depending etiology
🖋️multiple factors affect it
🔎 improves survival and LR mortality
📍Risk of HCC remains the same: don’t stop screening
@anahitarabiee.bsky.social
#liversky
#TLM25
Reposted by Atoosa Rabiee
😀🇦🇹 multisociety (gastroenterology & hepatology, diabetology & obesity) consensus on MASLD (& MetALD!)
🤝Well-aligned with @easlnews.bsky.social CPGs
😟Reimbursement currently restricted to semaglutide for T2DM
🤔Reimbursement in your country?
🖇️: rdcu.be/eLAde
#LiverSky @georg-semmler.bsky.social
🤝Well-aligned with @easlnews.bsky.social CPGs
😟Reimbursement currently restricted to semaglutide for T2DM
🤔Reimbursement in your country?
🖇️: rdcu.be/eLAde
#LiverSky @georg-semmler.bsky.social
November 8, 2025 at 3:02 AM
😀🇦🇹 multisociety (gastroenterology & hepatology, diabetology & obesity) consensus on MASLD (& MetALD!)
🤝Well-aligned with @easlnews.bsky.social CPGs
😟Reimbursement currently restricted to semaglutide for T2DM
🤔Reimbursement in your country?
🖇️: rdcu.be/eLAde
#LiverSky @georg-semmler.bsky.social
🤝Well-aligned with @easlnews.bsky.social CPGs
😟Reimbursement currently restricted to semaglutide for T2DM
🤔Reimbursement in your country?
🖇️: rdcu.be/eLAde
#LiverSky @georg-semmler.bsky.social
November 8, 2025 at 1:47 AM
November 7, 2025 at 11:57 PM
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update
If you take care of patients with #HCC, do not miss this new update from BCLC
#liversky
@easlnews.bsky.social
www.journal-of-hepatology.eu/article/S016....
If you take care of patients with #HCC, do not miss this new update from BCLC
#liversky
@easlnews.bsky.social
www.journal-of-hepatology.eu/article/S016....
October 27, 2025 at 5:21 PM
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update
If you take care of patients with #HCC, do not miss this new update from BCLC
#liversky
@easlnews.bsky.social
www.journal-of-hepatology.eu/article/S016....
If you take care of patients with #HCC, do not miss this new update from BCLC
#liversky
@easlnews.bsky.social
www.journal-of-hepatology.eu/article/S016....
In anticipation of registration for @bavenocoop.bsky.social VIII
Do not miss this new publication on
refining Baveno VII criteria for CSPH
individual-patient data meta-analysis
#liversky
pubmed.ncbi.nlm.nih.gov/41138818/
@easlnews.bsky.social
Do not miss this new publication on
refining Baveno VII criteria for CSPH
individual-patient data meta-analysis
#liversky
pubmed.ncbi.nlm.nih.gov/41138818/
@easlnews.bsky.social
October 27, 2025 at 5:18 PM
In anticipation of registration for @bavenocoop.bsky.social VIII
Do not miss this new publication on
refining Baveno VII criteria for CSPH
individual-patient data meta-analysis
#liversky
pubmed.ncbi.nlm.nih.gov/41138818/
@easlnews.bsky.social
Do not miss this new publication on
refining Baveno VII criteria for CSPH
individual-patient data meta-analysis
#liversky
pubmed.ncbi.nlm.nih.gov/41138818/
@easlnews.bsky.social
Once bleeding is controlled with banding:
Can duration of octreotide infusion be shortened?
In this RCT, 1 v 5 days of Oct infusion post successful EVL was non inferior in prevention of bleeding and all-cause mortality
#liversky
@amcollegegastro.bsky.social
pubmed.ncbi.nlm.nih.gov/41090987/
Can duration of octreotide infusion be shortened?
In this RCT, 1 v 5 days of Oct infusion post successful EVL was non inferior in prevention of bleeding and all-cause mortality
#liversky
@amcollegegastro.bsky.social
pubmed.ncbi.nlm.nih.gov/41090987/
October 27, 2025 at 5:16 PM
Once bleeding is controlled with banding:
Can duration of octreotide infusion be shortened?
In this RCT, 1 v 5 days of Oct infusion post successful EVL was non inferior in prevention of bleeding and all-cause mortality
#liversky
@amcollegegastro.bsky.social
pubmed.ncbi.nlm.nih.gov/41090987/
Can duration of octreotide infusion be shortened?
In this RCT, 1 v 5 days of Oct infusion post successful EVL was non inferior in prevention of bleeding and all-cause mortality
#liversky
@amcollegegastro.bsky.social
pubmed.ncbi.nlm.nih.gov/41090987/
📌A dual burden
HCC risk is increased in MetALD compared to MASLD
In a large cohort of VA patients, HCC risk
MASLD>>MetALD>>ALD
#liversky
@easlnews.bsky.social
www.sciencedirect.com/science/arti...
HCC risk is increased in MetALD compared to MASLD
In a large cohort of VA patients, HCC risk
MASLD>>MetALD>>ALD
#liversky
@easlnews.bsky.social
www.sciencedirect.com/science/arti...
October 27, 2025 at 5:12 PM
📌A dual burden
HCC risk is increased in MetALD compared to MASLD
In a large cohort of VA patients, HCC risk
MASLD>>MetALD>>ALD
#liversky
@easlnews.bsky.social
www.sciencedirect.com/science/arti...
HCC risk is increased in MetALD compared to MASLD
In a large cohort of VA patients, HCC risk
MASLD>>MetALD>>ALD
#liversky
@easlnews.bsky.social
www.sciencedirect.com/science/arti...
Anecdotally, I have noticed this in my patients. Great to see a publication supporting this.
Meta-Analysis of irAE using ICI in HCC
irAEs correlated with superior PFS & OS
specially derm, endocrine & low-grade events
#liversky
onlinelibrary.wiley.com/doi/10.1111/...
Meta-Analysis of irAE using ICI in HCC
irAEs correlated with superior PFS & OS
specially derm, endocrine & low-grade events
#liversky
onlinelibrary.wiley.com/doi/10.1111/...
Meta‐Analysis: Immune‐Related Adverse Events Are Associated With Improved Effectiveness of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
irAEs, particularly dermatologic, endocrine and low-grade events, were associated with improved ICIs effectiveness in HCC. Early irAEs detection and corticosteroid management preserve survival benefi...
onlinelibrary.wiley.com
October 27, 2025 at 5:05 PM
Anecdotally, I have noticed this in my patients. Great to see a publication supporting this.
Meta-Analysis of irAE using ICI in HCC
irAEs correlated with superior PFS & OS
specially derm, endocrine & low-grade events
#liversky
onlinelibrary.wiley.com/doi/10.1111/...
Meta-Analysis of irAE using ICI in HCC
irAEs correlated with superior PFS & OS
specially derm, endocrine & low-grade events
#liversky
onlinelibrary.wiley.com/doi/10.1111/...
📌 AGA clinical practice update on ascites and hyponatremia
@amergastroassn.bsky.social
#liversky
www.gastrojournal.org/article/S001...
@amergastroassn.bsky.social
#liversky
www.gastrojournal.org/article/S001...
October 27, 2025 at 4:58 PM
📌 AGA clinical practice update on ascites and hyponatremia
@amergastroassn.bsky.social
#liversky
www.gastrojournal.org/article/S001...
@amergastroassn.bsky.social
#liversky
www.gastrojournal.org/article/S001...
Reposted by Atoosa Rabiee
⏳ Just 5 months left for #BavenoVIII!
🗓️ 27-28 March 2026 (👶 Pediatric Symposium: 29 March)
📍 Baveno, Italy
🌐 The event will take place in a hybrid formula — both in person and online.
🧠 Call for abstracts is now open!
🔗 More info at: baveno8.org
🧵
🗓️ 27-28 March 2026 (👶 Pediatric Symposium: 29 March)
📍 Baveno, Italy
🌐 The event will take place in a hybrid formula — both in person and online.
🧠 Call for abstracts is now open!
🔗 More info at: baveno8.org
🧵
October 27, 2025 at 1:45 PM
⏳ Just 5 months left for #BavenoVIII!
🗓️ 27-28 March 2026 (👶 Pediatric Symposium: 29 March)
📍 Baveno, Italy
🌐 The event will take place in a hybrid formula — both in person and online.
🧠 Call for abstracts is now open!
🔗 More info at: baveno8.org
🧵
🗓️ 27-28 March 2026 (👶 Pediatric Symposium: 29 March)
📍 Baveno, Italy
🌐 The event will take place in a hybrid formula — both in person and online.
🧠 Call for abstracts is now open!
🔗 More info at: baveno8.org
🧵
Reposted by Atoosa Rabiee
➡️What #livertransplant candidates should get #GLP1-RA?
➡️Best timing for #bariatricsurgery in transplant?
➡️Data for #GLP1-RA in #cirrhosis?
🚨check out our @amjtransplant.bsky.social best practices for #obesity & liver transplant 👇
doi.org/10.1016/j.aj...
#liversky #GIsky #transplant
➡️Best timing for #bariatricsurgery in transplant?
➡️Data for #GLP1-RA in #cirrhosis?
🚨check out our @amjtransplant.bsky.social best practices for #obesity & liver transplant 👇
doi.org/10.1016/j.aj...
#liversky #GIsky #transplant
October 26, 2025 at 10:23 AM
➡️What #livertransplant candidates should get #GLP1-RA?
➡️Best timing for #bariatricsurgery in transplant?
➡️Data for #GLP1-RA in #cirrhosis?
🚨check out our @amjtransplant.bsky.social best practices for #obesity & liver transplant 👇
doi.org/10.1016/j.aj...
#liversky #GIsky #transplant
➡️Best timing for #bariatricsurgery in transplant?
➡️Data for #GLP1-RA in #cirrhosis?
🚨check out our @amjtransplant.bsky.social best practices for #obesity & liver transplant 👇
doi.org/10.1016/j.aj...
#liversky #GIsky #transplant
Changes in trend and comparison of outcomes of TACE vs TARE as bridge therapy for patients with HCC on LT list
#liversky
@aasldnews.bsky.social
#liversky
@aasldnews.bsky.social
October 14, 2025 at 1:45 AM
Changes in trend and comparison of outcomes of TACE vs TARE as bridge therapy for patients with HCC on LT list
#liversky
@aasldnews.bsky.social
#liversky
@aasldnews.bsky.social
Important study on use of ICI post-transplant
Only one rejection!
#liversky
@aasldnews.bsky.social
journals.lww.com/lt/abstract/...
Only one rejection!
#liversky
@aasldnews.bsky.social
journals.lww.com/lt/abstract/...
October 14, 2025 at 1:44 AM
Important study on use of ICI post-transplant
Only one rejection!
#liversky
@aasldnews.bsky.social
journals.lww.com/lt/abstract/...
Only one rejection!
#liversky
@aasldnews.bsky.social
journals.lww.com/lt/abstract/...
Ever wonder what happens to your liver after binge drinking?
This study showed
📌increased hepatic fat fraction by 2.5-fold in healthy adults
📌increased liver stiffness
📌increased plasma triglycerides
Good news:
All normalized with 10 days of abstinence
#liversky
www.jhep-reports.eu/cms/10.1016/...
This study showed
📌increased hepatic fat fraction by 2.5-fold in healthy adults
📌increased liver stiffness
📌increased plasma triglycerides
Good news:
All normalized with 10 days of abstinence
#liversky
www.jhep-reports.eu/cms/10.1016/...
October 14, 2025 at 1:40 AM
Ever wonder what happens to your liver after binge drinking?
This study showed
📌increased hepatic fat fraction by 2.5-fold in healthy adults
📌increased liver stiffness
📌increased plasma triglycerides
Good news:
All normalized with 10 days of abstinence
#liversky
www.jhep-reports.eu/cms/10.1016/...
This study showed
📌increased hepatic fat fraction by 2.5-fold in healthy adults
📌increased liver stiffness
📌increased plasma triglycerides
Good news:
All normalized with 10 days of abstinence
#liversky
www.jhep-reports.eu/cms/10.1016/...
Optimal sequencing post immunotherapy for HCC as first line
A good overview
#liversky
@easlnews.bsky.social
www.jhep-reports.eu/article/S258...
A good overview
#liversky
@easlnews.bsky.social
www.jhep-reports.eu/article/S258...
October 14, 2025 at 1:37 AM
Optimal sequencing post immunotherapy for HCC as first line
A good overview
#liversky
@easlnews.bsky.social
www.jhep-reports.eu/article/S258...
A good overview
#liversky
@easlnews.bsky.social
www.jhep-reports.eu/article/S258...
Eye opening statistics re: HCC surveillance and how underutilized the guidelines are
any HCC surveillance a little over 50%
biannual surveillance 10%
#liversky
onlinelibrary.wiley.com/doi/epdf/10....
any HCC surveillance a little over 50%
biannual surveillance 10%
#liversky
onlinelibrary.wiley.com/doi/epdf/10....
Meta‐Analysis: Utilisation of Hepatocellular Carcinoma Surveillance
Meta-analysis of 48 studies (1.28 M individuals) shows HCC surveillance remains underutilised despite guideline recommendations: only 54% of at-risk patients receive any ultrasound-based surveillance...
onlinelibrary.wiley.com
October 14, 2025 at 1:33 AM
Eye opening statistics re: HCC surveillance and how underutilized the guidelines are
any HCC surveillance a little over 50%
biannual surveillance 10%
#liversky
onlinelibrary.wiley.com/doi/epdf/10....
any HCC surveillance a little over 50%
biannual surveillance 10%
#liversky
onlinelibrary.wiley.com/doi/epdf/10....
RCT comparing TJ liver biopsy and HVPG vs EUS LB and PPG measurement
Would LOVE to hear @juanc60.bsky.social and @virginiahdezgea.bsky.social editorial on this paper
#liversky
@amergastroassn.bsky.social
www.cghjournal.org/article/S154...
Would LOVE to hear @juanc60.bsky.social and @virginiahdezgea.bsky.social editorial on this paper
#liversky
@amergastroassn.bsky.social
www.cghjournal.org/article/S154...
EUS-GUIDED LIVER BIOPSY AND PORTAL PRESSURE MEASUREMENT COMPARED TO TRANSJUGULAR APPROACH: A RANDOMIZED CONTROLLED TRIAL
The transjugular (TJ) technique is recommended for the simultaneous evaluation of
portal hypertension and hepatic fibrosis, with the hepatic venous pressure gradient
(HVPG) and liver biopsy (LB), resp...
www.cghjournal.org
October 14, 2025 at 1:26 AM
RCT comparing TJ liver biopsy and HVPG vs EUS LB and PPG measurement
Would LOVE to hear @juanc60.bsky.social and @virginiahdezgea.bsky.social editorial on this paper
#liversky
@amergastroassn.bsky.social
www.cghjournal.org/article/S154...
Would LOVE to hear @juanc60.bsky.social and @virginiahdezgea.bsky.social editorial on this paper
#liversky
@amergastroassn.bsky.social
www.cghjournal.org/article/S154...
Comprehensive review on evolution of immunotherapy for HCC
#liversky
#HCC
@aasldnews.bsky.social
journals.lww.com/hep/abstract...
#liversky
#HCC
@aasldnews.bsky.social
journals.lww.com/hep/abstract...
October 14, 2025 at 1:18 AM
Comprehensive review on evolution of immunotherapy for HCC
#liversky
#HCC
@aasldnews.bsky.social
journals.lww.com/hep/abstract...
#liversky
#HCC
@aasldnews.bsky.social
journals.lww.com/hep/abstract...